CJC-1295 + Ipamorelin Blend
ALSO SOLD AS CJC/Ipa · CJC-Ipamorelin
See the stack breakdown →Last reviewed 2026-10-30
Our read Opinion
No trials of the combination were found. CJC-1295 alone raised GH/IGF-1 in early human trials; those long-acting CJC-1295 results do not validate every product labeled CJC-1295.
- Type
- Research-only / unapproved
- Regulatory status
- No FDA approval for the blend
- Compounding status
- Not allowed (blends excluded)
- FDA-approved indications
- None
- Evidence level
- Small/early human studies
- Routes studied
- —
- WADA
- Prohibited
- Developer
- —
Claims made by researchers, companies and users. Inclusion does not mean the claim is verified.
- —Claimed to increase natural growth hormone pulses for fat loss, lean muscle, sleep quality and recovery
CJC-1295 activates the GHRH receptor; ipamorelin activates the ghrelin receptor to stimulate GH release. Complementary receptor actions do not prove clinical synergy.
Not a peptide: a pre-mixed blend of CJC-1295 + Ipamorelin. Neither component nor the blend is FDA-approved; FDA identifies safety concerns for both components.
Statuses change; check the linked primary source.
Momentum Opinion
Watch
0 news items in last 30 days
Hormone changes are not proof of better recovery, sleep or longevity. The blend adds uncertainty to already limited component evidence.
No news yet for this peptide.
Information only. Not medical advice. Listing a compound is not an endorsement or a recommendation to obtain or use it. Ratings and "Our Take" are editorial opinion. Full disclaimer.